GNF-2
SIGMA/G9420 - ≥98% (HPLC), solid
Synonym: 3-
CAS Number: 778270-11-4
Empirical Formula (Hill Notation): C18H13F3N4O2
Molecular Weight: 374.32
MDL Number: MFCD09265253
Linear Formula: C18H13F3N4O2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | off-white |
| form | solid |
| InChI | 1S/C18H13F3N4O2/c19-18(20 |
| InChI key | WEVYNIUIFUYDGI-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | NC(=O)c1cccc(c1)-c2cc(Nc3 |
| solubility | DMSO: ≥5 mg/mL |
| H2O: <2 mg/mL | |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | GNF-2 belongs to a new class of Bcr-abl inhibitors. GNF-2 appears to bind to the myristoyl binding pocket, an allosteric site distant from the active site, stabilizing the inactive form of the kinase. It inhibits Bcr-abl phosphorylation with an IC50 of 267 nM, but does not inhibit a panel of 63 other kinases, including native c-Abl, and shows complete lack of toxicity towards cells not expressing Bcr-Abl. GNF-2 shows great potential for a new class of inhibitor to study Bcr-abl activity and to treat resistant Chronic myelogenous leukemia (CML), which is caused the Bcr-Abl oncoprotein. |
| Biochem/physiol Actions: | GNF-2 is a Bcr-abl kinase inhibitor and antiangiogenic agent with exclusive antiproliferative activity toward Bcr-abl-transformed cells. |
| Features and Benefits: | This compound is a featured product for Kinase Phosphatase Biology research. Click here to discover more featured Kinase Phosphatase Biology products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: | This compound is featured on the Abl page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

